Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating Hemay005 tablets with midazolam (midazolam maleate tablets) in psoriasis patients has b…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis [Phase 1]
A Phase 1 multiple ascending-dose study of XmAb®27564 in psoriasis and atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis [Phase 2]
A Phase 2 study evaluating the effectiveness and safety of BMS-986322 in adults with moderate-to-severe psoriasis has completed. Results hav…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: MIcrovascular dysfuNction In Moderate-severe Psoriasis [Phase 4]
This Phase 4 clinical trial update reports results on microvascular dysfunction in adults with moderate-to-severe psoriasis and cardiovascul…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis [NA]
Clinical trial evaluating hemoperfusion with Efferon CT for severe psoriasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis [Phase 4]
A Phase 4 multicenter randomized double-blind trial evaluated whether adding methotrexate improves and maintains response to anti-TNF therap…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis [Phase 2]
A Phase 2 trial evaluating SAR441566 in adults with plaque psoriasis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Risankizumab Long-term Remission Study [Phase 4]
Update on the Phase 4 Risankizumab long-term remission study shows the trial is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: High Dose Risankizumab for Psoriasis [Phase 2]
A Phase 2 trial evaluating high-dose risankizumab for psoriasis has completed, with results posted on 2025-10-24.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis [Phase 3]
Long-term Phase 3 trial assessing the safety and efficacy of Deucravacitinib for psoriasis; the study is currently active but not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases [NA]
Clinical trial update on a high-touch, low-cost approach to improving mental health outcomes in patients with psoriatic diseases; the study …
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis [Phase 1, Phase 2]
Proof-of-concept Phase 1/2 study of AX-158 in patients with mild to moderate plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis [Phase 1]
Phase 1 trial evaluating safety, tolerability, and clinical response of SAR441566 versus placebo in mild to moderate psoriasis. The study st…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
A clinical trial update on the efficacy of tildrakizumab for difficult-to-treat areas of psoriasis (palmar, genital, scalp, plantar, and nai…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®) [Phase 1]
A Phase 1 drug-drug interaction study assessed how HS-10374 interacts with Yasmin (drospirenone/ethinyl estradiol) in participants with psor…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan
A completed clinical trial in Taiwan evaluated changes in psoriasis disease state after subcutaneous risankizumab in adults. The study was s…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects [Phase 4]
An open-label, single-dose Phase 4 study to evaluate safety, tolerability, and pharmacokinetics of brodalumab in pediatric subjects with pso…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis
Clinical trial update indicates a long-term safety study of Siliq (brodalumab) versus other therapies for adults with moderate-to-severe pso…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis
The completed trial assessed how IL-17 and IL-23 inhibitors affect markers of subclinical atherosclerosis in psoriasis patients, reporting r…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Post-Marketing Surveillance Study of OTEZLA
This document reports the completion of a post-marketing surveillance study evaluating the safety of Otezla (apremilast) in patients with ps…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Periodontal Health and Quality of Life in Psoriasis Patients
This clinical trial update indicates completion of a study assessing periodontal health and quality of life in patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream
A completed clinical trial evaluating tolerability, efficacy, and treatment adherence of Wynzora Cream in psoriasis patients.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Analysis of Influence Factors on Osteopenia in Different Treatment of Psoriasis
This completed clinical trial analyzes factors influencing osteopenia among patients treated for psoriasis across different therapies.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy
A completed clinical trial evaluated how clinical and psychological factors influence treatment satisfaction in psoriasis patients treated w…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Effectiveness of a Digital Health Application for Psoriasis [NA]
This ClinicalTrials.gov entry indicates an active but not recruiting study evaluating the effectiveness of a digital health application for …